Le Lézard
Classified in: Ebola virus, Health, Business
Subjects: ECO, ACC

Additional cost increases require new comprehensive price increases


STOCKHOLM, Sept. 13, 2022 /PRNewswire/ -- Hygiene and health company Essity is being affected by additional cost increases. Prices for electricity and gas have risen sharply in Europe since July 2022. Costs for the company's raw materials have also risen significantly in the third quarter. Essity is therefore announcing new comprehensive price increases for all product categories and markets. 

"The cost headwinds have worsened further. We will manage this situation through new comprehensive price increases and energy price surcharges and are continuing to invest in our strong offering under leading brands and to supply essential hygiene and health solutions to Essity's customers and consumers every day," says Magnus Groth, President and CEO, Essity.

The timing and degree of the price increases will be managed locally.

NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 07:00 CET on September 13, 2022. 

Karl Stoltz, Media Relations Manager, +46 709 426 338

For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 733 13 30 55, [email protected]
Johan Karlsson, Vice President Investor Relations, +46 705 11 15 81, [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/essity/r/additional-cost-increases-require-new-comprehensive-price-increases,c3629813

The following files are available for download:

https://mb.cision.com/Main/15798/3629813/1625914.pdf

Additional cost increases require new comprehensive price increases

SOURCE Essity


These press releases may also interest you

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...



News published on and distributed by: